Analyst Consensus ?
ConsensusHold34 ratings
Bullish1132.4%
Neutral2058.8%
Bearish38.8%
Omnicom Group Inc. · OMC · FY2026 Q1 · Calendar Q2 2026
Omnicom Q1: Revenue Beats on IPG Synergy Progress, Agentic AI Media Buys Go Live
Omnicom's first full quarter as a combined entity with Interpublic produced a clear top- and bottom-line beat: reported revenue of $6.24 billion versus $5.85 billion estimated and EPS of $1.90 versus $1.82 estimated. Core revenue grew 6.7% (3.9% organic) and adjusted EBITDA margin expanded 240 basis points to 14.8%, providing early evidence that the IPG integration is capturing synergies on schedule. The company repurchased $2.8 billion of stock in the quarter alone, putting it on pace toward a $5 billion twelve-month target, and completed $1 billion of non-core revenue disposals with $152 million in proceeds. Product milestones were tangible rather than aspirational: the first real-world Agentic AI media buys executed through the AdCP protocol with publishers, and Acxiom data integrated into the Omni platform. Despite these results, the market reaction was negative -- an abnormal…
Reported After market closeNYSECommunication Services
$23.54B market cap
100quality score
Company context
Snapshot as of publicationOmnicom Group Inc., through its network of subsidiaries, stands as a premier global provider of comprehensive advertising, marketing, and corporate communications solutions. The company's core expertise extends across pivotal areas such as traditional and digital advertising, customer relationship management (CRM), public relations, and specialized healthcare communications. Its extensive service portfolio delivers a wide array of strategic and creative solutions. These offerings include branding, content creation, corporate social responsibility consulting, crisis management, data analytics, digital transformation, entertainment and experiential marketing, financial/corporate business-to-business advertising, graphic design, investor…
Earnings scorecard
Reported versus consensus
Reported EPS
$1.90
Consensus $2
EPS surprise
+4.4%
Reported versus consensus
Reported revenue
$6.24B
Consensus $5.85B
Revenue surprise
+6.7%
Reported versus consensus
Earnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$79.61Current
$32Low
$103.38Average
$230High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 31, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Goldman Sachs | Buy | Sell | Upgrade | Jun 3, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | May 1, 2026 |
| Citigroup | Buy | Buy | Maintain | Apr 30, 2026 |
| UBS | Buy | Buy | Maintain | Mar 20, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Feb 23, 2026 |
| B of A Securities | Underperform | Neutral | Downgrade | Jan 5, 2026 |
| Wells Fargo | Overweight | Equal Weight | Upgrade | Sep 23, 2025 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 10, 2025 |
| Macquarie | Outperform | Outperform | Maintain | Dec 11, 2024 |
| MoffettNathanson | Neutral | Neutral | Maintain | Apr 17, 2024 |
| Exane BNP Paribas | Outperform | Neutral | Upgrade | Mar 28, 2024 |
| Edward Jones | Hold | Buy | Downgrade | Jun 14, 2022 |
| Argus Research | Buy | Hold | Upgrade | Mar 18, 2022 |
| Evercore ISI Group | In Line | Underperform | Upgrade | Nov 2, 2020 |
| Wolfe Research | Perform | Peer Perform | Maintain | Jul 23, 2020 |
| CFRA | Hold | Hold | Maintain | Apr 28, 2020 |
| BMO Capital | Market Perform | Outperform | Downgrade | Jul 15, 2019 |
| Argus | Hold | Buy | Downgrade | Jul 23, 2018 |
| Moffett Nathanson | Sell | Sell | Maintain | Jun 19, 2018 |
| Atlantic Equities | Neutral | Underweight | Upgrade | Mar 2, 2018 |
| RBC Capital | Sector Perform | Outperform | Downgrade | Feb 16, 2018 |
| Telsey Advisory Group | Outperform | Market Perform | Upgrade | Oct 18, 2017 |
| Credit Suisse | Neutral | Neutral | Maintain | Oct 18, 2017 |
| Bank of America | Neutral | Neutral | Maintain | Mar 2, 2017 |
| FBR Capital | Market Perform | Market Perform | Maintain | Feb 10, 2016 |
| Nomura | Neutral | Neutral | Maintain | Apr 22, 2015 |
| Pivotal Research | Sell | Hold | Downgrade | Apr 13, 2015 |
| Albert Fried & Co. | Market Perform | Underweight | Upgrade | May 29, 2014 |
| Albert Fried | Market Perform | Underweight | Upgrade | May 29, 2014 |
| Lazard | Buy | Neutral | Upgrade | Sep 5, 2013 |
| Evercore Partners | Overweight | Equal Weight | Upgrade | Aug 12, 2013 |
| Deutsche Bank | Hold | Hold | Maintain | Jul 29, 2013 |
| Wedbush | Neutral | Neutral | Maintain | Apr 15, 2013 |
| Jefferies | Hold | Hold | Maintain | Apr 3, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $79.61. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| MoffettNathanson | Michael Nathanson | $85 | $86.22 | +6.8% | Jul 29, 2026 |
| Goldman Sachs | Adam Berlin | $146 | $75.22 | +83.4% | Jun 3, 2026 |
| Morgan Stanley | Analyst unavailable | $83 | $76.72 | +4.3% | Apr 30, 2026 |
| Barclays | Analyst unavailable | $90 | $83.26 | +13.1% | Feb 23, 2026 |
| Morgan Stanley | Thomas Yeh | $82 | $77.6 | +3.0% | Feb 19, 2026 |
| Morgan Stanley | Analyst unavailable | $88 | $80.56 | +10.5% | Dec 16, 2025 |
| UBS | Adam Berlin | $108 | $73.34 | +35.7% | Dec 5, 2025 |
| Barclays | Julien Roch | $82 | $81.23 | +3.0% | Oct 23, 2025 |
| Wells Fargo | Steven Cahall | $91 | $74.53 | +14.3% | Sep 23, 2025 |
| Barclays | Analyst unavailable | $80 | $70.69 | +0.5% | Jun 25, 2025 |
| Citigroup | Michael Rollins | $32 | $73.89 | -59.8% | Apr 11, 2025 |
| Macquarie | Tim Nollen | $120 | $105.49 | +50.7% | Oct 16, 2024 |
| UBS | Adam Berlin | $124 | $104.02 | +55.8% | Oct 16, 2024 |
| Bank of America Securities | Adrien de Saint Hilaire | $89 | $98.75 | +11.8% | Sep 5, 2024 |
| J.P. Morgan | David Karnovsky | $108 | $89.72 | +35.7% | Jun 21, 2024 |
| Barclays | Julien Roch | $110 | $93.19 | +38.2% | May 7, 2024 |
| Argus Research | Kristina Ruggeri | $103 | $93.8 | +29.4% | Apr 23, 2024 |
| UBS | Adam Berlin | $117 | $92.54 | +47.0% | Apr 17, 2024 |
| Morgan Stanley | Benjamin Swinburne | $105 | $92.5 | +31.9% | Apr 17, 2024 |
| Wells Fargo | Steven Cahall | $106 | $90.96 | +33.1% | Apr 17, 2024 |
| BNP Paribas | Lina Ghayor | $115 | $95.16 | +44.5% | Mar 28, 2024 |
| Macquarie | Tim Nollen | $100 | $85.88 | +25.6% | Jan 5, 2024 |
| Citigroup | Jason Bazinet | $112 | $85.09 | +40.7% | Jan 5, 2024 |
| Rosenblatt Securities | Barton Crockett | $230 | $86.68 | +188.9% | Dec 20, 2023 |
| Citigroup | Jason Bazinet | $113 | $74.86 | +41.9% | Sep 21, 2023 |
| Morgan Stanley | Benjamin Swinburne | $100 | $79.91 | +25.6% | Aug 21, 2023 |
| Wells Fargo | Analyst unavailable | $109 | $94.74 | +36.9% | Feb 8, 2023 |
| J.P. Morgan | Analyst unavailable | $100 | $90.92 | +25.6% | Feb 8, 2023 |
| Morgan Stanley | Analyst unavailable | $95 | $90.92 | +19.3% | Feb 8, 2023 |
| Morgan Stanley | Analyst unavailable | $85 | $91.94 | +6.8% | Feb 6, 2023 |
| Morgan Stanley | Analyst unavailable | $75 | $77.42 | -5.8% | Dec 19, 2022 |
| Barclays | Analyst unavailable | $70 | $70.06 | -12.1% | Jul 21, 2022 |
| Wells Fargo | Analyst unavailable | $84 | $69.54 | +5.5% | Jul 20, 2022 |
| J.P. Morgan | Analyst unavailable | $85 | $63.84 | +6.8% | Jul 8, 2022 |
| Citigroup | Analyst unavailable | $85 | $63.43 | +6.8% | Jul 7, 2022 |
| Morgan Stanley | Analyst unavailable | $70 | $66.8 | -12.1% | Jun 10, 2022 |
| New Street | Alexia Quadrani | $96 | $85.31 | +20.6% | Apr 20, 2022 |
| Citigroup | Jason Bazinet | $96 | $71.62 | +20.6% | Jul 21, 2021 |
Track every rating change on OMC the moment it posts. Free to start.
Start freeMarket reaction
event-close to next-session close
Stock move
-0.9%
Event window
SPY move
-0.0%
Same window
Abnormal move
-0.9%
Stock minus SPY
Volume
1.8×
Versus trailing sessions
Subsequent drift
-2.8%
Up to 20 sessions
OMCSPY benchmark
Follow OMC with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeTranscript intelligence
What changed
Core revenue grew 6.7% (3.9% organic) in the first combined quarter, versus the prior quarter's focus on closing the IPG deal and framing the integration roadmap. Adjusted EBITDA margin expanded 240 bps to 14.8%, demonstrating early synergy realization that was still prospective in Q4. Share repurchases accelerated to $2.8 billion in Q1, with a $5 billion twelve-month target replacing the prior $2.5 billion accelerated buyback program. Non-core disposal target increased from $2.5 billion to $3.2 billion in revenue, with completed disposals rising from $800 million to $1 billion. Agentic AI media buying moved from a planned roadmap item to real-world execution via the AdCP protocol with publishers. Guidance sentiment shifted from not provided in Q4 to maintained in Q1, though formal adjusted EPS guidance was still not issued.
Guidance delta
Management maintained its full-year outlook, reiterating $900 million in cost-reduction synergies for 2026 and $1.5 billion in annual run-rate synergies by mid-2028. The share repurchase target was elevated from the prior $2.5 billion accelerated program to $5 billion over the next twelve months. No formal adjusted EPS growth guidance was provided, which analysts flagged as a concern. The disposal program expanded from $2.5 billion to $3.2 billion in non-core revenue to be divested.
Key takeaways
- Reported revenue of $6.24 billion beat estimates by 6.7%; EPS of $1.90 beat by 4.4%.
- Core revenue of $5.6 billion grew 6.7% with 3.9% organic growth in the first combined quarter with IPG.
- Adjusted EBITDA margin expanded 240 bps to 14.8%, reflecting early synergy capture.
- $2.8 billion of share repurchases executed in Q1; $5 billion targeted over the next 12 months.
- $900 million of cost-reduction synergies expected in 2026, scaling to $1.5 billion by mid-2028.
- Disposals of $3.2 billion in non-core revenue underway; $1 billion completed with $152 million in Q1 proceeds.
Management priorities
- Execute IPG integration and capture $900 million in 2026 cost synergies, scaling to $1.5 billion by mid-2028.
- Scale Omni AI and Agentic media buying capabilities across all client engagements.
- Complete remaining non-core disposals totaling $3.2 billion in annual revenue.
- Repurchase $5 billion of shares over the next 12 months.
- Leverage Acxiom data integration to enhance targeting and measurement across the platform.
Related earnings events
Communication ServicesSources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-07-30T21:42:46.645039+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-30T21:42:46.642322+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.